
ESMO/LinkedIn
Apr 8, 2025, 18:01
ESMO recommendations released to provide a roadmap to facilitate the implementation of MTBs in clinical practice
ESMO (European Society for Medical Oncology) shared a post on LinkedIn:
“New ESMO recommendations released to provide a roadmap to facilitate the implementation of molecular tumour boards (MTBs) in clinical practice.
The recommendations published in Annals of Oncology provide a structured framework to:
- Define core MTB composition
- Establish structured workflows for case selection, data integration & follow-up
- Set documentation and reporting standards
- Introduce quality indicators to assess MTB performance
These are some of the key areas to be addressed to foster consistent and effective MTB operations across diverse healthcare environments and to optimise precision oncology.
Read the ESMO Daily Reporter article.”
More posts featuring ESMO.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 15, 2025, 14:40
Apr 15, 2025, 14:12
Apr 15, 2025, 13:41
Apr 15, 2025, 13:28
Apr 15, 2025, 13:00